Abstract:Cerebral small vessel disease (SVD) causes lacunar stroke and intracerebral hemorrhage, and is the most common pathology underlying vascular cognitive impairment. Increasingly, the importance of other clinical features of SVD is being recognized including motor impairment, (vascular) parkinsonism, impaired balance, falls, and behavioral symptoms, such as depression, apathy, and personality change. Epidemiological data show a high prevalence of the characteristic magnetic resonance imaging (MRI) features of white matter hyperintensities and lacunar infarcts in community studies, and recent data suggest that it is also a major health burden in low- and middle-income countries. In this review, we cover advances in diagnosis, imaging, clinical presentations, pathogenesis, and treatment.The two most common pathologies underlying SVD are arteriolosclerosis caused by aging, hypertension, and other conventional vascular risk factors, and cerebral amyloid angiopathy (CAA) caused by vascular deposition of β-amyloid. We discuss the revised Boston criteria of CAA based on MRI features, which have been recently validated. Imaging is providing important insights into pathogenesis, including improved detection of tissue damage using diffusion tensor imaging (DTI) leading to its use to monitor progression and surrogate endpoints in clinical trials. Advanced MRI techniques can demonstrate functional or dynamic abnormalities of the blood vessels, while the high spatial resolution provided by ultrahigh field MRI at 7 T allows imaging of individual perforating arteries for the first time, and the measurement of flow velocity and pulsatility within these arteries. DTI and structural network analysis have highlighted the importance of network disruption in mediating the effect of different SVD pathologies in causing a number of symptoms, including cognitive impairment, apathy, and gait disturbance.Despite the public health importance of SVD, there are few proven treatments. We review the evidence for primary prevention, and recent data showing how intensive blood pressure lowering reduces white matter hyperintensities (WMH) progression and delays the onset of cognitive impairment. There are few treatments for secondary prevention, but a number of trials are currently evaluating novel treatment approaches. Recent advances have implicated molecular processes related to endothelial dysfunction, nitric oxide synthesis, blood-brain barrier integrity, maintenance and repair of the extracellular matrix, and inflammation. Novel treatment approaches are being developed to a number of these targets. Finally, we highlight the importance of large International collaborative initiatives in SVD to address important research questions and cover a number which have recently been established.

Retinal capillary microvessel morphology changes are associated with vascular damage and dysfunction in cerebral small vessel disease

Functional and morphological changes of the retinal vessels in Alzheimer’s disease and mild cognitive impairment

Retinal structure and vessel density changes in cerebral small vessel disease

Optical coherence tomography-based assessment of retinal vascular pathology in cerebral small vessel disease

Retinal vascular density as a potential biomarker of diabetic cerebral small vessel disease

The Application of Optical Coherence Tomography Angiography in Cerebral Small Vessel Disease, Ischemic Stroke, and Dementia: A Systematic Review

Abstract WP487: Retinal Vessel Tortuosity Correlates with White Matter Hyperintensities and Cerebral Microbleeds in Subjects with Cognitive Decline

Superficial White Matter Microstructure Affects Processing Speed in Cerebral Small Vessel Disease

Deep Microbleeds and Periventricular White Matter Disintegrity Are Independent Predictors of Attention/executive Dysfunction in Non-Dementia Patients with Small Vessel Disease.

Quantity and Morphology of Perivascular Spaces: Associations with Vascular Risk Factors and Cerebral Small Vessel Disease

Cerebrovascular Function in Sporadic and Genetic Cerebral Small Vessel Disease

Reduced Coupling Between the Global Blood-Oxygen-level-dependent Signal and Cerebrospinal Fluid Inflow is Associated with the Severity of Small Vessel Disease.

Cerebrovascular Reactivity in Patients With Small Vessel Disease: A Cross-Sectional Study

Microvascular pathology and morphometrics of sporadic and hereditary small vessel diseases of the brain

Differences in retinal microvasculature between large artery atherosclerosis and small artery disease: an optical coherence tomography angiography study

Small vessel disease and clinical outcomes after IV rt-PA treatment

Optical coherence tomography angiography as a potential screening tool for cerebral small vessel diseases

Cognitive Impairment in Cerebral Small Vessel Disease Is Associated with Corpus Callosum Microstructure Changes Based on Diffusion MRI

Cerebral small vessel disease: Recent advances and future directions

Microvascular Impairment in Patients With Cerebral Small Vessel Disease Assessed With Arterial Spin Labeling Magnetic Resonance Imaging: A Pilot Study

The Association of Retinal Microvasculature With Gray Matter Changes and Structural Covariance Network: A Voxel-Based Morphometry Study